Vincerx Agrees to Merger with Oqory

 

Proposed merger would add a differentiated Phase 3 TROP2 Antibody-drug Conjugate (ADC) to the combined company’s pipeline

https://www.globenewswire.com/news-release/2024/12/27/3002352/0/en/Vincerx-Pharma-Enters-into-a-Binding-Term-Sheet-for-a-Strategic-Merger-with-Oqory-Inc.html